Dr. A Hillary Steinhart is a gastroenterologist at Mount Sinai Hospital and University Health Network and a Professor of Medicine at the Department of Medicine, Temerty Faculty of Medicine, University of Toronto. He is also an Associate Member of the Mount Sinai Hospital Lunenfeld Tanenbaum Research Institute and the Department of Health Policy Management and Evaluation at the University of Toronto. He is the Director of Clinical Trials at the Mount Sinai Hospital Inflammatory Bowel Disease Centre. He has had a very active medical practice for over 30 years with his clinical work being focused almost exclusively on caring for patients with Crohn’s disease and ulcerative colitis. He divides his time between patient care, clinical research and teaching. From 2000 to 2015, he was the Head of the Combined Division of Gastroenterology at Mount Sinai Hospital and University Health Network in Toronto. From 2015 to 2018, he was the Medical Lead of the Inflammatory Bowel Disease Centre at Mount Sinai Hospital. He is a past chair of Crohn’s and Colitis Canada’s Scientific and Medical Advisory Committee and a former recipient of that Foundation’s Research Leadership Award. His research interests include the evaluation of new therapeutic strategies for the treatment of inflammatory bowel disease, meta-analysis and clinical trials methodology, disease severity evaluation and complications of inflammatory bowel.
Dr. A Hillary Steinhart is a gastroenterologist at Mount Sinai Hospital and University Health Network and a Professor of Medicine at the Department of Medicine, Temerty Faculty of Medicine, University of Toronto. He is also an Associate Member of the Mount Sinai Hospital Lunenfeld Tanenbaum Research Institute and the Department of Health Policy Management and Evaluation at the University of Toronto. He is the Director of Clinical Trials at the Mount Sinai Hospital Inflammatory Bowel Disease Centre. He has had a very active medical practice for over 30 years with his clinical work being focused almost exclusively on caring for patients with Crohn’s disease and ulcerative colitis. He divides his time between patient care, clinical research and teaching. From 2000 to 2015, he was the Head of the Combined Division of Gastroenterology at Mount Sinai Hospital and University Health Network in Toronto. From 2015 to 2018, he was the Medical Lead of the Inflammatory Bowel Disease Centre at Mount Sinai Hospital. He is a past chair of Crohn’s and Colitis Canada’s Scientific and Medical Advisory Committee and a former recipient of that Foundation’s Research Leadership Award. His research interests include the evaluation of new therapeutic strategies for the treatment of inflammatory bowel disease, meta-analysis and clinical trials methodology, disease severity evaluation and complications of inflammatory bowel.